|
|
||||||||
J Thorac Cardiovasc Surg 2004;127:399-405
© 2004 The American Association for Thoracic Surgery
Surgery for acquired cardiovascular disease |
a Department of Cardiothoracic Surgery and Ludwig-Boltzmann-Institute for Cardiosurgical Research, University of Vienna, Vienna, Austria
Received for publication March 22, 2003; revisions received May 1, 2003; accepted for publication June 23, 2003.
* Address for reprints: Guenter Weigel, MD, Department of Cardiothoracic Surgery, University of Vienna, AKH, Waehringer Guertel 18-20, 1090 Vienna, Austria
guenter.weigel{at}akh-wien.ac.at
OBJECTIVE: We compared 3 different decellularization protocols in porcine heart valves for efficiency of complete cell removal and potential for recellularization.
METHODS: Porcine aortic and pulmonary roots were treated with trypsin, sodium-dodecyl-sulphate, or a new method using 0.25% tert-octylphenyl-polyoxyethylen in combination with sodium-deoxycholate. After a subsequent ribonuclease digestion, specimens were seeded with in vitro expanded human saphenous vein endothelial cells and myofibroblasts.
RESULTS: After treatment with trypsin and subsequent ribonuclease digestion, endothelial attachment took place; however, xenogenic cells were still visible within the matrix. Unexpectedly, when human cells were seeded onto specimens that had been decellularized with sodium-dodecyl-sulphate, the matrices were surrounded by nonviable endothelial cell fragments, indicating a toxic influence of the ionic detergent; 0.25% tert-octylphenyl-polyoxyethylen together with sodium-deoxycholate completely removed porcine cells and enabled host recellularization.
CONCLUSION: Compared with trypsin and sodium-dodecyl-sulphate involving decellularization procedures, reported to be effective in cell removal and susceptible to recellularization with human cells, only the porcine matrix treated with a new detergent-based decellularization method using 0.25% tert-octylphenyl-polyoxyethylen/sodium-deoxycholate followed by nuclease digestion presented an excellent scaffold for recellularization with human cells.
This article has been cited by other articles:
![]() |
P. M. Dohmen and W. Konertz Decellularization of xenogenic biologic tissue. Ann. Thorac. Surg., June 1, 2008; 85(6): 2163 - 2163. [Full Text] [PDF] |
||||
![]() |
F. Juthier, A. Vincentelli, J. Gaudric, D. Corseaux, O. Fouquet, C. Calet, T. L. Tourneau, V. Soenen, C. Zawadzki, O. Fabre, et al. Decellularized heart valve as a scaffold for in vivo recellularization: Deleterious effects of granulocyte colony-stimulating factor J. Thorac. Cardiovasc. Surg., April 1, 2006; 131(4): 843 - 852. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ota, Y. Sawa, S. Iwai, T. Kitajima, Y. Ueda, C. Coppin, H. Matsuda, and Y. Okita Fibronectin-Hepatocyte Growth Factor Enhances Reendothelialization in Tissue-Engineered Heart Valve Ann. Thorac. Surg., November 1, 2005; 80(5): 1794 - 1801. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Vesely Heart Valve Tissue Engineering Circ. Res., October 14, 2005; 97(8): 743 - 755. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ketchedjian, A. L. Jones, P. Krueger, E. Robinson, K. Crouch, L. Wolfinbarger Jr, and R. Hopkins Recellularization of Decellularized Allograft Scaffolds in Ovine Great Vessel Reconstructions Ann. Thorac. Surg., March 1, 2005; 79(3): 888 - 896. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |